Kay J S, Litin B S, Woolfenden J M, Chvapil M, Herschler J
Ophthalmic Surg. 1986 Oct;17(10):626-30.
Antitumor and antifibroblast agents show promise as adjuncts after glaucoma filtration surgery in reducing postoperative scarring and failure. We used nuclear imaging in rabbits to investigate periocular clearance of one such agent (57Co-bleomycin). Sub-Tenon injection was compared to other delivery techniques. Our results showed that a collagen sponge and a silastic disc implant with a microhole prolonged drug delivery when compared to sub-Tenon injection alone or injection with a viscosity enhancing agent (0.5% sodium hyaluronate). We theorize that if an antifibroblast agent can be delivered in small and sustained amounts after filtration surgery, this may prolong bleb longevity and avoid unnecessary drug toxicity.
抗肿瘤和成纤维细胞药物作为青光眼滤过手术后减少术后瘢痕形成和手术失败的辅助药物显示出前景。我们在兔子身上使用核成像技术来研究一种这样的药物(57Co-博来霉素)在眼周的清除情况。将Tenon囊下注射与其他给药技术进行了比较。我们的结果表明,与单独的Tenon囊下注射或与增粘剂(0.5%透明质酸钠)联合注射相比,带有微孔的胶原海绵和硅橡胶盘植入物可延长药物递送时间。我们推测,如果一种抗成纤维细胞药物能够在滤过手术后以小剂量持续递送,这可能会延长滤过泡寿命并避免不必要的药物毒性。